Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AGA Rapid Clinical Practice Update on the Management of Patients Taking GLP-1 Receptor Agonists Prior to Endoscopy: Communication
Jana G. Hashash, Christopher C. Thompson, Andrew Y. Wang
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 4, pp. 705-707
Closed Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Increased Risk of Aspiration Pneumonia Associated With Endoscopic Procedures Among Patients With Glucagon-like Peptide 1 Receptor Agonist Use
Yee Hui Yeo, Srinivas Gaddam, Wee Han Ng, et al.
Gastroenterology (2024) Vol. 167, Iss. 2, pp. 402-404.e3
Closed Access | Times Cited: 46
Quantified Metrics of Gastric Emptying Delay by Glucagon-Like Peptide-1 Agonists: A Systematic Review and Meta-Analysis With Insights for Periprocedural Management
Brent Hiramoto, Thomas R. McCarty, Nayna A. Lodhia, et al.
The American Journal of Gastroenterology (2024) Vol. 119, Iss. 6, pp. 1126-1140
Closed Access | Times Cited: 26
Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period
Tammy L. Kindel, Andrew Y. Wang, Anupama Wadhwa, et al.
Surgery for Obesity and Related Diseases (2024) Vol. 20, Iss. 12, pp. 1183-1186
Open Access | Times Cited: 22
Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions
Ryan J. Jalleh, Christopher K. Rayner, Trygve Hausken, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 10, pp. 957-964
Closed Access | Times Cited: 19
Glucagon-Like Peptide-1 Receptor Agonists Do Not Increase Aspiration During Upper Endoscopy in Patients With Diabetes
Trevor Barlowe, Chelsea Anderson, Robert S. Sandler, et al.
Clinical Gastroenterology and Hepatology (2024)
Closed Access | Times Cited: 18
Glucagon‐like peptide‐1 receptor agonists: a narrative review of clinical pharmacology and implications for peri‐operative practice
David A. Milder, Tamara Y. Milder, S. Liang, et al.
Anaesthesia (2024) Vol. 79, Iss. 7, pp. 735-747
Open Access | Times Cited: 17
Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study
Wajd Alkabbani, Karine Suissa, KRISTINE D. GU, et al.
BMJ (2024), pp. e080340-e080340
Closed Access | Times Cited: 17
Glucagon‐like peptide‐1 receptor agonists and upper endoscopy: a real‐world experience
Pichamol Jirapinyo, Noppachai Siranart, Christopher C. Thompson
Obesity (2025)
Closed Access | Times Cited: 3
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Gastric Mucosal Visibility and Retained Gastric Contents During Esophagogastroduodenoscopy.
Malcolm Chapman, Dalton A. Norwood, Christopher Price, et al.
Gastrointestinal Endoscopy (2024) Vol. 100, Iss. 5, pp. 923-927
Closed Access | Times Cited: 14
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Upper Gastrointestinal Endoscopy: A Meta-Analysis
Antonio Facciorusso, Daryl Ramai, Jahnvi Dhar, et al.
Clinical Gastroenterology and Hepatology (2024)
Open Access | Times Cited: 14
Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks
Wissam Ghusn, Maria D. Hurtado
Obesity Pillars (2024) Vol. 12, pp. 100127-100127
Open Access | Times Cited: 14
Clinical Outcomes and Safety of Upper Endoscopy While on Glucagon-Like Peptide-1 Receptor Agonists
Stephen A. Firkins, J. C. Yates, Neehal Shukla, et al.
Clinical Gastroenterology and Hepatology (2024)
Open Access | Times Cited: 9
Perioperative Use of GLP-1 Receptor Agonists in Patients Undergoing Cardiac Procedures: A Scoping Review
Oscar Wookey, Anna Galligan, Bruce Wilkie, et al.
Heart Lung and Circulation (2025)
Closed Access | Times Cited: 1
Optimizing Bowel Preparation Quality for Colonoscopy: Consensus Recommendations by the US Multi-Society Task Force on Colorectal Cancer
Brian C. Jacobson, Joseph C. Anderson, Carol A. Burke, et al.
The American Journal of Gastroenterology (2025)
Closed Access | Times Cited: 1
Multisociety Clinical Practice Guidance for the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in the Perioperative Period
Tammy L. Kindel, Andrew Y. Wang, Anupama Wadhwa, et al.
Clinical Gastroenterology and Hepatology (2024)
Open Access | Times Cited: 8
Comparison of societal guidance on perioperative management of glucagon-like peptide-1 receptor agonists: implications for clinical practice and future investigations
Marvin G. Chang, Edward A. Bittner
Canadian Journal of Anesthesia/Journal canadien d anesthésie (2024) Vol. 71, Iss. 9, pp. 1302-1315
Closed Access | Times Cited: 7
Safe Continuation of Glucagon-like Peptide 1 Receptor Agonists at Endoscopy: A Case Series of 57 Adults Undergoing Endoscopic Sleeve Gastroplasty
Daniel B. Maselli, Daniel J. Lee, Danse Bi, et al.
Obesity Surgery (2024) Vol. 34, Iss. 7, pp. 2369-2374
Closed Access | Times Cited: 6
No association between semaglutide and postoperative pneumonia in people with diabetes undergoing elective surgery
Blayne Welk, J. Andrew McClure, Brooke Carter, et al.
Diabetes Obesity and Metabolism (2024)
Open Access | Times Cited: 6
Risk of Aspiration Pneumonitis After Elective Esophagogastroduodenoscopy in Patients on Glucagon-Like Peptide-1 Receptor Agonists
Ruaa Al Sakka Amini, Abdellatif Ismail, Maysarah Mahdi Alaqrabawi, et al.
Cureus (2024)
Open Access | Times Cited: 6
Real-World Impact of GLP-1 Receptor Agonists on Endoscopic Patient Outcomes in an Ambulatory Setting: A Retrospective Study at a Large Tertiary Center
Ernesto Robalino Gonzaga, Aimen Farooq, Abdul Mohammed, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5403-5403
Open Access | Times Cited: 6
Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
Michael Nakhla, Ambica Nair, Prachi Balani, et al.
Cardiovascular Drugs and Therapy (2024)
Closed Access | Times Cited: 6
Should We Stop Glucagon-Like Peptide-1 Receptor Agonists Before Surgical or Endoscopic Procedures? Balancing Limited Evidence With Clinical Judgment
Guillermo E. Umpierrez, Francisco J. Pasquel, Elizabeth W. Duggan, et al.
Journal of Diabetes Science and Technology (2024)
Open Access | Times Cited: 5
Glucagon-like Peptide-1 Receptor Agonists and Capsule Endoscopy in Patients with Diabetes: A Matched Cohort Study
Tarek Odah, Asrita Vattikonda, Mark E. Stark, et al.
Gastrointestinal Endoscopy (2024)
Closed Access | Times Cited: 5
GLP1-RA use prior to endoscopy is associated with low retained gastric contents: a multicenter cross-sectional analysis.
Jennifer Phan, Patrick Chang, Danny Issa, et al.
The American Journal of Gastroenterology (2024)
Closed Access | Times Cited: 4
The role of incretin receptor agonists in the treatment of obesity
Thomas Först, Christophe De Block, Stefano Del Prato, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 10, pp. 4178-4196
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top